Literature DB >> 7504912

Early pulmonary disease in systemic sclerosis: a comparison between carbon monoxide transfer factor and static lung compliance.

A Scheja1, A Akesson, P Wollmer, F A Wollheim.   

Abstract

OBJECTIVES: Pulmonary disease is responsible for considerable morbidity and mortality in systemic sclerosis (SSc). Static lung compliance (Cst) has been observed to be decreased more often in SSc than the vital capacity, indicating that it is a sensitive measure of lung restriction. In this study Cst was compared with the carbon monoxide transfer factor (TLCO), a widely used measure of the function of the alveolar capillary unit, and with lung volumes in 59 patients with confirmed or suspected SSc.
METHODS: Cst was calculated from the oesophageal pressure at different lung volumes and the TLCO was measured with the single breath method.
RESULTS: The TLCO was found to be the earliest sign of pulmonary disease and was already decreased at a disease duration of one year or less. Surprisingly, no relation was found between the TLCO and smoking habits, nor the degree of peripheral vascular disease. The TLCO correlated with the Cst and vital capacity.
CONCLUSIONS: An early pulmonary lesion can be identified in patients with SSc with decreased TLCO at a time when no fibrotic changes are manifested.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504912      PMCID: PMC1005169          DOI: 10.1136/ard.52.10.725

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  25 in total

1.  PULMONARY FUNCTION IN SCLERODERMA.

Authors:  B RITCHIE
Journal:  Thorax       Date:  1964-01       Impact factor: 9.139

2.  AN EARLY PULMONARY PHYSIOLOGIC ABNORMALITY IN PROGRESSIVE SYSTEMIC SCLEROSIS (DIFFUSE SCLERODERMA).

Authors:  R J WILSON; G P RODNAN; E D ROBIN
Journal:  Am J Med       Date:  1964-03       Impact factor: 4.965

3.  Spirometric studies in normal subjects. I. Forced expirograms in subjects between 7 and 70 years of age.

Authors:  E BERGLUND; G BIRATH; J BJURE; G GRIMBY; I KJELLMER; L SANDQVIST; B SODERHOLM
Journal:  Acta Med Scand       Date:  1963-02

4.  Lung function in patients with systemic sclerosis.

Authors:  D T HUGHES; F I LEE
Journal:  Thorax       Date:  1963-03       Impact factor: 9.139

5.  The measurement of pulmonary diffusing capacity for carbon monoxide by a rebreathing method.

Authors:  B M LEWIS; T H LIN; F E NOE; E J HAYFORD-WELSING
Journal:  J Clin Invest       Date:  1959-11       Impact factor: 14.808

6.  A method for determination of pulmonary elastic recoil and resistance at a regulated flow rate.

Authors:  B Jonson
Journal:  Scand J Clin Lab Invest       Date:  1969-09       Impact factor: 1.713

7.  Pulmonary involvement in systemic sclerosis. Association with anti-Scl 70 antibody and digital pitting.

Authors:  M N Manoussakis; S H Constantopoulos; A E Gharavi; H M Moutsopoulos
Journal:  Chest       Date:  1987-09       Impact factor: 9.410

8.  Evaluation and management of scleroderma lung disease using bronchoalveolar lavage.

Authors:  R M Silver; K S Miller; M B Kinsella; E A Smith; S I Schabel
Journal:  Am J Med       Date:  1990-05       Impact factor: 4.965

9.  Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance.

Authors:  N K Harrison; A R Glanville; B Strickland; P L Haslam; B Corrin; B J Addis; R Lawrence; A B Millar; C M Black; M Turner-Warwick
Journal:  Respir Med       Date:  1989-09       Impact factor: 3.415

10.  Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis.

Authors:  A M Stupi; V D Steen; G R Owens; E L Barnes; G P Rodnan; T A Medsger
Journal:  Arthritis Rheum       Date:  1986-04
View more
  1 in total

1.  Spontaneous pneumothorax in a patient with systemic sclerosis.

Authors:  M Zeuner; U Müller-Ladner; V D Mohr; B Lang
Journal:  Clin Rheumatol       Date:  1996-03       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.